Fragmin 2500iu Injection is a low molecular weight heparin (LMWH) widely used as an anticoagulant to prevent and manage blood clots. Blood clots, such as deep vein thrombosis (DVT) and pulmonary embolism (PE), can pose serious health risks if left untreated. Dalteparin works by inhibiting clotting factors in the blood, particularly Factor Xa and thrombin, effectively reducing the formation of harmful clots while maintaining normal blood flow.

This injectable anticoagulant is essential for patients undergoing surgery, prolonged immobilization, or those with medical conditions that increase the risk of thrombosis. Its low molecular weight ensures a predictable anticoagulant effect with fewer complications compared to standard heparin. Fragmin 2500iu Injection is administered via subcutaneous injection, making it suitable for both hospital and at-home use under proper guidance.

The 2500 I.U. dosage is commonly prescribed for prophylaxis, helping high-risk patients avoid potentially life-threatening complications like strokes, heart attacks, or post-surgical venous thromboembolism. With proper adherence to the prescribed course, Dalteparin provides effective prevention and management of blood clots, ensuring patient safety and faster recovery.